A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials

Overview of attention for article published in Frontiers in oncology, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 29 X posts from 25 X users, with an upper bound of 73,857 followers.

RT @gerryhanna: Meta-analysis of randomised studies (n=5) of OD vs BD radiotherapy in LS-SCLC suggests a better O.S. with BD radiotherapy (…

BID CCRT appears to be better than OD CCRT for limited-stage SCLC, with better antitumor effects #radonc #lcsm https://t.co/kWLNtTgg9o

RT @gerryhanna: Meta-analysis of randomised studies (n=5) of OD vs BD radiotherapy in LS-SCLC suggests a better O.S. with BD radiotherapy (…

Interesting thread #lcsm #radonc #sclc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 25 additional X posts.